Procarbazine: Difference between revisions

Revision as of 08:55, 27 March 2024

Property	Information
Drug Name	Procarbazine
FDA Approval	Yes
Used for	Glioblastoma
Clinical Trial Phase	Not specified
Clinical Trial Explanation	Not specified
Common Side Effects	Hematological toxicity, nausea, and neurological effects
OS without	Not specified
OS with	Not specified
PFS without	Not specified
PFS with	Not specified
Usefulness Rating	3
Usefulness Explanation	Not specified
Toxicity Level	4
Toxicity Explanation	The drug Procarbazine is considered quite toxic. This rating is based on the common side effects like hematological toxicity, which refers to potential harm to your blood cells, nausea, and neurological effects such as headache or dizziness. These side effects are relatively common and could significantly affect your day-to-day life. Remember, all treatments come with potential risks, and it's important to discuss these with your doctor.

Notes: Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness.

From Ben Williams Book: Not specified

Loading comments...

@@ Line 9: / Line 9: @@
 |notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness.
 |category=Other Chemotherapy and Cancer Drugs
+|toxicity_level=4
+|toxicity_explanation=The drug Procarbazine is considered quite toxic. This rating is based on the common side effects like hematological toxicity, which refers to potential harm to your blood cells, nausea, and neurological effects such as headache or dizziness. These side effects are relatively common and could significantly affect your day-to-day life. Remember, all treatments come with potential risks, and it's important to discuss these with your doctor.
 }}